![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1648096
¼¼°èÀÇ °¢¸· Á¦Ç° ½ÃÀå(2024³â) : ºÐ¼®(2023-2029³â)2024 Cornea Products Market Report: Global Analysis for 2023 to 2029 |
¼¼°èÀÇ °¢¸· Á¦Ç° ½ÃÀå(2024³â)¿¡¼´Â Ç«½º µð½ºÆ®·ÎÇÇ Ä¡·áÀÇ ¼¼°è ½ÃÀå ±âȸ¿¡ °üÇÑ »õ·Î¿î ¼½¼ÇÀ» ¸¶·ÃÇÏ¿© ´ëü Ç«½º µð½ºÆ®·ÎÇÇ Ä¡·á ±âȸÀÇ ÀáÀçÀûÀÎ ½ÃÀå ¿µÇâ·ÂÀ» Áö¿ªº°·Î °ËÁõÇϰí, »óÀ§ 10°³±¹ÀÇ ÀáÀçÀû ½ÃÀå¿¡ °üÇÑ ÁÖ¿ä ÁöÇ¥¸¦ Á¦½ÃÇϰí ÀÖ½À´Ï´Ù.
¶ÇÇÑ 6°³ Ä«Å×°í¸®¿Í 52°³ Áúȯ¿¡ °üÇÑ °¢¸· Áúȯ Àα¸ ÃßÁ¤¡¤¿¹ÃøÀ» ¾÷µ¥ÀÌÆ®Çϰí, °¢¸·À̽ÄÀÇ ÇýÅÃÀ» ¹ÞÀ» °¡´É¼ºÀÌ ÀÖ´Â ÃÑÀα¸ÀÇ ¿¹ÃøÀ» ¼öÁ¤Çß½À´Ï´Ù.
2024³â °¢¸· Á¦Ç° ½ÃÀå °³¿ä'´Â °¢¸· ÁúȯÀÇ °³¿ä¿Í 6°³ Áúȯ Ä«Å×°í¸®¿¡¼ÀÇ Àα¸ ¿¹ÃøÀ» Á¦½ÃÇϰí ÀÖ½À´Ï´Ù. °¢¸·À̽Ä, Ä¡·á¿ë ·»Áî, PTK, °¢¸·³» ¸µ ¼¼±×¸ÕÆ®, °¢¸· Å©·Î½º¸µÅ· µîÀÇ °¢¸· Á¦Ç°°ú Ä¡·á¹ý, ¸ÅÃâ ¿¹Ãø¿¡ ´ëÇØ ³íÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ Àå±â Á¦°ø Á¤Ã¥, ±ÔÁ¦¿Í Á¤Ã¥, °¢¸· Àü¹®ÀÇ, ¾È±¸ÀºÇà, ±âŸ Á¶Á÷ÀÇ ¿ªÇÒ¿¡ ´ëÇØ¼µµ ¸®ºäÇϰí ÀÖ½À´Ï´Ù.
½ÃÀå ¿¹Ãø¿¡¼ 50»ç ÀÌ»ó ±â¾÷ÀÇ 70 ÀÌ»óÀÇ Á¦Ç°À» °ËÅäÇϰí, ¾ÆÁ÷ ¼öÀÍÀÌ ¿¹ÃøµÇÁö ¾ÊÀº ½Å±â¼úÀÇ ÇâÈÄ ÆÄÀÌÇÁ¶óÀο¡ ´ëÇØ¼µµ ³íÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼ö¹é°³ÀÇ ¾È±¸ÀºÇà, ¿¬±¸±â°ü, NGO¿¡ ´ëÇØ¼µµ °í·ÁÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÁÖ¿ä ½ÃÀå Âü¿© ±â¾÷ 12»çÀÇ »ó¼¼ ±â¾÷ °³¿äµµ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù.
°¢¸· Ä¡·á Àüü¿Í Áúȯ Àα¸ºÎÅÍ Á¦Ç°À» Á¦Á¶ÇÏ´Â ±â¾÷±îÁö ´Ù·ç°í ÀÖ½À´Ï´Ù.
The "2024 Cornea Products Market Report" features a new section on the global market opportunity for Fuchs' dystrophy treatment, examining the potential market impact of alternate Fuchs' dystrophy treatment opportunity by region and presenting key metrics for the top 10 potential markets.
The report also includes updated estimates for population with corneal disease for six categories and 52 diseases and a revised forecast for the total population that could benefit from a cornea transplant, with breakouts for those with access to ophthalmic care and those who could benefit from upcoming therapies.
The "2024 Cornea Products Market Report" provides an overview of corneal diseases and gives estimates for the populations in six disease categories. The report discusses cornea products and treatments and revenue forecasts for cornea transplants, therapeutic lenses, PTK, intrastromal corneal ring segments, and corneal crosslinking. It also reviews organ donation policy, regulations, and the role of cornea specialists, eye banks, and other organizations.
This report considers over 70 products from more than 50 companies in its market forecasts and discusses the upcoming pipeline of new technologies that have yet to recognize revenue. Hundreds of eye banks, research institutes, and NGOs are also considered. Also included are 12 in-depth company profiles on key market players.
This new report covers the entire cornea treatment landscape-from the diseased populations to the companies manufacturing the products. Our coverage includes: